← All organizations

Genitope Corporation

For profit

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

May 1, 2007

Defunct as of Sep 17, 2008

Timeline

1990s

Jun 1, 1996
Genitope Corporation— Founded

2000s

Sep 17, 2008
Genitope Corporation— Defunct

Drugs by trial phase (9 distinct, 6 trials)

Phase 3 (6 own, 0 via acquisition)

Phase 2 (2 own, 0 via acquisition)

Other trials (1 own, 0 via acquisition)

id-klh vaccine

Indications

Studied for

Recent trials (8)

NCT00510471Lead sponsorPhase 2May 1, 2007
NCT00302861Lead sponsorPhase 1/Phase 2Mar 1, 2006
NCT00071955Study chairPhase 2Mar 1, 2003
NCT00071955Lead sponsorPhase 2Mar 1, 2003
NCT00017290Lead sponsorPhase 3Nov 1, 2000
NCT00017290Study chairPhase 3Nov 1, 2000
NCT00574886CollaboratorN/AJul 1, 2000
NCT00004198CollaboratorPhase 2Jun 1, 1999

Details

Founded: Fremont, CA, US Jun 1, 1996
Last known activity: May 1, 2007